A miniaturized flow-through cell to evaluate skin permeation of endoxifen

International Journal of Pharmaceutics

Volumn 441, Issue 1-2, 2013, Pages 433-440

  Mah, Choon Siong ^a   Kochhar, Singh Jaspreet ^a   Ong, Pei Shi ^a   Kang, Lifeng ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Breast cancer; Endoxifen; Flow through diffusion cell; Polydimethylsiloxane; Transdermal drug delivery

Indexed keywords

ENDOXIFEN; LIMONENE; PENETRATION ENHANCING AGENT;

ARTICLE; CONTROLLED STUDY; DRUG PENETRATION; DRUG TRANSPORT; EVALUATION; FLOW THROUGH CELL; NANODEVICE; NANOFABRICATION; NONHUMAN; PRIORITY JOURNAL; RAT; SKIN INJURY; SKIN PERMEABILITY; VALIDATION PROCESS;

ANIMALS; CYCLOHEXENES; DIFFUSION; ESTROGEN ANTAGONISTS; EXCIPIENTS; MODELS, BIOLOGICAL; PERMEABILITY; RATS; RHODAMINES; SKIN ABSORPTION; TAMOXIFEN; TERPENES; XANTHONES;

EID: 84872803716     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2012.11.011     Document Type: Article

References (53)

1. A. Ahmad, S.M. Ali, and M.U. Ahmad Orally administered endoxifen is a new therapeutic agent for breast cancer Breast Cancer Res. Treat. 122 2010 579 584
2. A. Ahmad, S. Shahabuddin, and S. Sheikh Endoxifen, a new cornerstone of breast cancer therapy: demonstration of safety, tolerability, and systemic bioavailability in healthy human subjects Clin. Pharmacol. Ther. 88 2010 814 817
3. M. Akazawa, T. Itoh, and K. Masaki An automated method for continuously monitoring diffusion cells in skin penetration studies Int. J. Pharm. 50 1989 53 60
4. E.O. Aranda, J. Esteve-Romero, and M. Rambla-Alegre Development of a methodology to quantify tamoxifen and endoxifen in breast cancer patients by micellar liquid chromatography and validation according to the ICH guidelines Talanta 84 2011 314 318
5. B.J. Aungst, N.J. Rogers, and E. Shefter Enhancement of naloxone penetration through human skin in vitro using fatty acids, fatty alcohols, surfactants, sulfoxides and amides Int. J. Pharm. 33 1986 225 234
6. B.W. Barry Lipid-protein-partitioning theory of skin penetration enhancement J. Control. Release 15 1991 237 248
7. L. Bartosova, and J. Bajgar Transdermal drug delivery in vitro using diffusion cells Curr. Med. Chem. 19 2012 4662 4670
8. N.H. Bellantone, S. Rim, and M.L. Francoeur Enhanced percutaneous- absorption via iontophoresis. 1. Evaluation of an in vitro system and transport of model compounds Int. J. Pharm. 30 1986 63 72
9. K.R. Brain, and K.A. Walters Molecular modeling of skin permeation enhancement by chemical agents K.A. Walters, J. Hadgraft, Pharmaceutical Skin Penetration Enhancement 1993 Marcel Dekker New York 389 416
10. R.M. Brand, J. Pike, and R.M. Wilson Sunscreens containing physical UV blockers can increase transdermal absorption of pesticides Toxicol. Ind. Health 19 2003 9 16
11. R.L. Bronaugh Diffusion cell design V.P. Shah, H.I. Maibach, Topical Drug Bioavailability, Bioequivalence and Penetration 1993 Plenum Press New York 120
12. R.L. Bronaugh, and R.F. Stewart Methods for in vitro percutaneous absorption studies IV: the flow-through diffusion cell J. Pharm. Sci. 74 1985 64 67
13. COLIPA, 1997. http://www.cosmeticseurope.eu/publications-cosmetics- europe-association/guidelines.html?view=item&id=26 (accessed 02.04.12).
14. M. Cordoba-Diaz, M. Nova, and B. Elorza Validation protocol of an automated in-line flow-through diffusion equipment for in vitro permeation studies J. Control. Release 69 2000 357 367
15. M. Del Re, A. Michelucci, and P. Simi Pharmacogenetics of anti-estrogen treatment of breast cancer Cancer Treat. Rev. 38 2011 442 450
16. Z. Desta, B.A. Ward, and N.V. Soukhova Comprehensive evaluation of tamoxifen sequential biotransformation by the human cytochrome P450 system in vitro: prominent roles for CYP3A and CYP2D6 J. Pharmacol. Exp. Ther. 310 2004 1062 1075
17. EBCTCG-Secretariat Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials Lancet 365 2005 1687 1717
18. B. Godin, and E. Touitou Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models Adv. Drug Deliv. Rev. 59 2007 1152 1161
19. Hanson, 2012. http://www.hansonresearch.com/ (accessed 26.06.12).
20. F.A. Holmes, and J.D. Liticker Pharmacogenomics of tamoxifen in a nutshell-and who broke the nutcracker? J. Oncol. Pract. 1 2005 155 159
21. J.M. Hoskins, L.A. Carey, and H.L. McLeod CYP2D6 and tamoxifen, DNA matters in breast cancer Nat. Rev. Cancer 9 2009 576 586
22. ICH, 1994. http://www.ich.org/products/guidelines/quality/quality-single/ article/validation-of-analytical-procedures-text-and-methodology.html (accessed 20.02.12).
23. A. Jemal, F. Bray, and M.M. Center Global cancer statistics CA Cancer J. Clin. 61 2011 69 90
24. M.D. Johnson, H. Zuo, and K.H. Lee Pharmacological characterization of 4-hydroxy-N-desmethyl tamoxifen, a novel active metabolite of tamoxifen Breast Cancer Res. Treat. 85 2004 151 159
25. L. Kang, B.G. Chung, and R. Langer Microfluidics for drug discovery and development: from target selection to product lifecycle management Drug. Discov. Today 13 2008 1 13
26. L. Kang, C.W. Yap, and P.F. Lim Formulation development of transdermal dosage forms: quantitative structure-activity relationship model for predicting activities of terpenes that enhance drug penetration through human skin J. Control. Release 120 2007 211 219
27. Y.S.R. Krishnaiah, V. Satyanarayana, and P. Bhaskar Effect of limonene on the in vitro permeation of nicardipine hydrochloride across the excised rat abdominal skin Pharmazie 57 2002 842 847
28. J.R. Lakowicz, I. Gryczynski, and V. Bogdanov Light quenching and fluorescence depolarization of rhodamine B and applications of this phenomenon to biophysics J. Phys. Chem. 98 1994 334 342
29. O. Lee, D. Ivancic, and R. Chatterton In vitro human skin permeation of endoxifen: potential for local transdermal therapy for primary prevention and carcinoma in situ of the breast Breast Cancer 3 2011 61 70
30. N. Li, M. Schwartz, and C. Ionescu-Zanetti PDMS compound adsorption in context J. Biomol. Screen. 14 2009 194 202
31. B. Martin, O. Watts, and B. Shroot A new diffusion cell-an automated method for measuring the pharmaceutical availability of topical dosage forms Int. J. Pharm. 49 1989 63 68
32. H.R. Moghimi, A.C. Williams, and B.W. Barry A lamellar matrix model for stratum corneum intercellular lipids. V. Effects of terpene penetration enhancers on the structure and thermal behaviour of the matrix Int. J. Pharm. 146 1997 41 54
33. S.F. Ng, J.J. Rouse, and F.D. Sanderson Validation of a static Franz diffusion cell system for in vitro permeation studies AAPS PharmSciTech 11 2010 1432 1441
34. NIH, U.S., 2009. http://clinicaltrials.gov/ct2/show/NCT00952731 (accessed 07.09.12).
35. NIH, U.S., 2011a. http://clinicaltrials.gov/ct2/show/NCT01273168 (accessed 20.02.12).
36. NIH, U.S., 2011b. http://clinicaltrials.gov/ct2/show/study/NCT01327781 (accessed 20.02.12).
37. R. Panchagnula, P.S. Salve, and N.S. Thomas Transdermal delivery of naloxone: effect of water, propylene glycol, ethanol and their binary combinations on permeation through rat skin Int. J. Pharm. 219 2001 95 105
38. J.H. Park, M.G. Allen, and M.R. Prausnitz Biodegradable polymer microneedles: fabrication, mechanics and transdermal drug delivery J. Control. Release 104 2005 51 66
39. Permegear, 2012. http://www.permegear.com/ilc14.htm (accessed 26.06.12).
40. ® and the Van Kel apparatus for in vitro release testing of topical semisolid formulations Pharm. Res. 18 2001 1440 1447
41. J. Šalamoun, M. Macka, and M. Nechvátal Identification of products formed during UV irradiation of tamoxifen and their use for fluorescence detection in high-performance liquid chromatography J. Chromatogr. A 514 1990 179 187
42. P.P. Sanghvi, and C.C. Collins Comparison of diffusion studies of hydrocortisone between the Franz cell and the enhancer cell Drug Dev. Ind. Pharm. 19 1993 1573 1585
43. D. Selzer, M.M. Abdel-Mottaleb, and T. Hahn Finite and infinite dosing: difficulties in measurements, evaluations and predictions Adv. Drug Deliv. Rev. 2012 10.1016/j.addr.2012.06.010
44. M.S. Singh, P.A. Francis, and M. Michael Tamoxifen, cytochrome P450 genes and breast cancer clinical outcomes Breast 20 2011 111 118
45. M. Sznitowska, S. Janicki, and A. Baczek Studies on the effect of pH on the lipoidal route of penetration across stratum corneum J. Control. Release 76 2001 327 335
46. K. Tojo, C.C. Chiang, and Y.W. Chien Drug permeation across the skin: effect of penetrant hydrophilicity J. Pharm. Sci. 76 1987 123 126
47. S. Tokumoto, K. Mori, and N. Higo Effect of electroporation on the electroosmosis across hairless mouse skin in vitro J. Control. Release 105 2005 296 304
48. M. Varshney, T. Khanna, and M. Changez Effects of AOT micellar systems on the transdermal permeation of glyceryl trinitrate Colloids Surf. B 13 1999 1 11
49. A.C. Williams, and B.W. Barry Skin absorption enhancers Crit. Rev. Ther. Drug Carrier Syst. 9 1992 305 353
50. J.J. Windheuser, J.L. Haslam, and L. Caldwell The use of N,N-diethyl-m-toluamide to enhance dermal and transdermal delivery of drugs J. Pharm. Sci. 71 1982 1211 1213
51. I. Wong, and C.M. Ho Surface molecular property modifications for poly(dimethylsiloxane) (PDMS) based microfluidic devices Microfluid. Nanofluid. 7 2009 291 306
52. X. Wu, J.R. Hawse, and M. Subramaniam The tamoxifen metabolite, endoxifen, is a potent antiestrogen that targets estrogen receptor alpha for degradation in breast cancer cells Cancer Res. 69 2009 1722 1727
53. K. Zhao, and J. Singh Mechanism(s) of in vitro percutaneous absorption enhancement of tamoxifen by enhancers J. Pharm. Sci. 89 2000 771 780